In addition, SHP2 inhibition reduced the proliferation of cultured human lupus T cells and decreased the production of IFN-γ and IL-17A/F in vitro, suggesting integral involvement of SHP2 in human lupus-associated immunopathology (203). This evidence concerns the gene IFNG and systemic lupus erythematosus.